$SOTK

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm SONO-TEK CORPORATION REPORTS FIRST QUARTER FISCAL 2027 RESULTS Exhibit 99.1 Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results Revenue Increased 10%; Gross Margin Expanded to 57%; Operating Income Increased 86%; Net Income Increased 67% Anticipati

Original reporting
Published Jul 8, 2026, 11:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 8, 2026, 11:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SOTK
Bullish
high confidence
Mentioned
$SOTK
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SOTKBullishMed
01

Why it matters

The filing is a fresh earnings-style datapoint with explicit margin and earnings improvements, and it reiterates a full-year revenue outlook of flat to modestly higher, primarily due to shipment timing and clean energy uncertainty.

02

Market read

Traders can reassess near-term expectations for profitability and revenue cadence based on the reported margin expansion, medical mix, and the stated shipment-timing driven outlook.

03

What to watch

Revenue growth is partly tied to shipment timing of large production platform orders; quarterly results may be volatile as the mix shifts toward higher-value systems.

Relevance 7/10Novelty 8/10Timing: after-hours/filing today with Q1 fiscal 2027 results and 1H/full-year outlook

Background

The 8-K (Item 2.02) includes Exhibit 99.1 with first quarter fiscal 2027 financial results for Sono-Tek, ended May 31, 2026, plus management commentary and outlook.

Company-level read

Ticker impact

$SOTKBullishHigh confidence
Context

Sono-Tek reported first-quarter fiscal 2027 results, with net sales up 10% and gross margin expanding to 57% from 52%.

Expected impact

Near-term bias positive, but tempered by guidance that full-year revenue is flat to modestly higher and backlog is down vs fiscal year-end.

Evidence & confidence

The filing provides concrete income statement datapoints (revenue, gross margin, operating income, net income) plus an outlook framework (1H growth, full-year flat to modestly higher) and balance-sheet context (no debt, backlog down from year-end).

Market effects

Signals strength in medical ultrasonic coating demand and higher-value production systems, while clean energy remains a headwind.

Medical demand strength is described across the U.S., Europe, and Asia, suggesting diversified end-market traction.

Backlog and shipment timing uncertainty implies uneven near-term revenue recognition, relevant for global manufacturing customers.

Counterpoint

Margin expansion may not be repeatable each quarter, and backlog is down versus the prior fiscal year-end, which can pressure subsequent revenue visibility.

Key entities

  • Sono-Tek Corporation

    Reports Q1 fiscal 2027 results, margin expansion, and medical-sector driven growth, with full-year revenue guidance flat to modestly higher.

Related articles

$SOTKMed

Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems

SONO TEK CORP (SOTK) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Sono-Tek Reports Fiscal Second Quarter and First Half 2027 Results Driven by Strong Medical Sector and Higher Value Production Systems First Half Revenue Increased 6% to $10.9 Million; Gross Margin Expanded to 55%; Operating Income Increased 41%; Medical Market Sales

$SOTKMed

Sono-Tek stock rises on record $3.6M production line order

Sono-Tek Corp (NASDAQ:SOTK) shares rose 3.9% premarket after the company said it received a $3.6 million order for an integrated advanced manufacturing production line for medical diagnostic device coating. Sono-Tek said it is its largest single-line order, placed by an existing customer moving to high-volume manufacturing, with shipment expected in fiscal 2028.

$SOTKMedAI 8/10

Sono-Tek Corporation Reports First Quarter Fiscal 2027 Results

Sono-Tek (Nasdaq: SOTK) reported first-quarter fiscal 2027 results for the quarter ended May 31, 2026. Net sales rose 10% to $5.66 million, gross margin expanded to 57% from 52%, operating income increased 86% to $897,000, and net income rose to $741,000 ($0.05 diluted). Cash was $16.65 million with no debt, and backlog was $7.73 million. The company expects continued 1H growth driven by medical demand and higher-value production systems.

$SOTKMedAI 9/10

Sono-Tek Corporation Q4 2026 Earnings Call Summary

Sono-Tek Corporation reported Q4 2026 results driven by a shift to higher-ASP, turnkey production systems. The company said medical demand rose 54% year over year, while clean energy orders fell 19% amid government policy changes. Gross margin increased to 51% and operating income rose 81%. Management projected growth and profitability in fiscal 2027 H1, with flat-to-modestly higher full-year revenue amid clean-energy uncertainty. Cash was $14.8 million with no debt.

$SOTKMedAI 9/10

Sono-Tek Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

Sono-Tek (Nasdaq: SOTK) reported FY2026 net sales of $20.9M (+2% YoY), gross margin of 51% (up from 47.5%), operating income of $1.82M (+81%), and net income of about $1.8M (+42%), according to the company. Q4 net sales were $5.6M (+10%). Backlog was $9.1M. The company expects continued 1H FY2027 revenue growth driven by medical and high-ASP systems; FY2027 revenue projected flat to modestly higher.